What You Should Know:
- NVIDIA today launched more than two dozen new microservices that allow healthcare enterprises worldwide to take advantage of the latest advances in generative AI from anywhere and on any cloud.
- The new suite of NVIDIA healthcare microservices includes optimized NVIDIA NIM AI models and workflows with industry-standard APIs, or application programming interfaces, to serve as building blocks for creating and deploying cloud-native applications. They offer advanced imaging, natural language and speech recognition, and digital biology generation, prediction and simulation.
Empowering Healthcare Innovation: Introducing NVIDIA NIM Healthcare Microservices
Moreover, NVIDIA’s suite of accelerated software development kits and tools, such as Parabricks, MONAI, NeMo, Riva, and Metropolis, are now accessible as NVIDIA CUDA-X microservices. These microservices, with 25 newly launched offerings, are poised to expedite healthcare workflows in drug discovery, medical imaging, and genomics analysis.
This advancement in microservices stands to catalyze transformation within healthcare organizations, particularly as generative AI opens up myriad opportunities for pharmaceutical firms, medical professionals, and healthcare facilities. These opportunities encompass screening vast arrays of drug compounds to propel medical advancements, improving the quality of patient data for early disease detection, and deploying more intelligent digital assistants.
By enabling researchers, developers, and practitioners to seamlessly integrate AI into both new and existing applications, these microservices empower them to operate across various environments—from cloud-based platforms to on-premises setups. This equips them with co-pilot capabilities, enhancing their efforts in life-saving endeavors.
“For the first time in history, we can represent the world of biology and chemistry in a computer, making computer-aided drug discovery possible,” said Kimberly Powell, vice president of healthcare at NVIDIA. “By helping healthcare companies easily build and manage AI solutions, we’re enabling them to harness the full power and potential of generative AI.”
NVIDIA NIM Healthcare Microservices for Inference presents a suite meticulously tailored to optimize inference operations across a spectrum of healthcare domains, including imaging, medical technology, drug discovery, and digital health. Within the NVIDIA AI Enterprise 5.0 software platform, NIM provides elevated capabilities in generative biology, chemistry, and molecular prediction.
These microservices incorporate specialized models such as MolMIM for generative chemistry, ESMFold for protein structure prediction, and DiffDock for comprehending drug-target interactions. Furthermore, VISTA 3D expedites the development of 3D segmentation models, while the Universal DeepVariant significantly accelerates genomic analysis, boasting a 50x speed improvement over CPU-based approaches.
Cadence, a computational software leader, integrates NVIDIA BioNeMo microservices into its Orion molecular design platform, enhancing drug discovery capabilities. Over 50 application providers, biotech firms, pharma companies, and medical imaging software makers utilize these microservices, including industry players like Amgen, Astellas, and DNA Nexus.
Generative AI is revolutionizing patient care, with companies like Hippocratic AI developing task-specific Generative AI Healthcare Agents powered by safety-focused LLM. Connected to NVIDIA’s Avatar Cloud Engine (ACE) microservices and utilizing NIM for low-latency inferencing, these agents conduct various patient interactions, from appointment scheduling to post-discharge follow-ups.
Abridge is pioneering an AI-powered clinical conversation platform that streamlines note drafting for clinicians, saving up to three hours daily. This system employs various AI technologies for real-time conversion of clinical conversations into structured, high-quality documentation, facilitating efficient patient care.
